|
시장보고서
상품코드
1789378
세계의 HSV 검사 시장 : HSV 유형별, 검체 유형별, 연령층별, 용도별, 최종사용자별, 지역별HSV Testing Market, By HSV Type, By Type, By Sample Type, By Age Group, By Application, By End User, By Geography |
||||||
HSV 검사 시장은 2025년에는 6억 4,240만 달러, 2032년에는 9억 7,230만 달러에 이르고, 2025-2032년 연평균 복합 성장률(CAGR)은 6.1%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 6억 4,240만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 : 2025-2032년 | 6.10% | 2032년 금액 예측 | 9억 7,230만 달러 |
세계 HSV 검사 시장은 광범위한 진단 검사 산업 중 중요한 부문으로, 전 세계 수백만 명이 앓고 있는 단순 포진 바이러스 감염을 감지하고 식별하는 데 초점을 맞추었습니다. HSV 검사는 PCR 기반 분석, 항원 검출 검사, 항체 기반 혈청학적 검사, 바이러스 배양 기술을 포함한 다양한 진단 방법을 포함하며, 각각 다양한 민감도와 특이도로 HSV-1 및 HSV-2 감염을 식별하도록 설계되었습니다.
성병에 대한 인식이 높아지고, 전 세계적으로 헤르페스 감염의 유병률이 증가하고, 조기 진단 및 치료 개입에 대한 중요성이 높아짐에 따라 시장의 중요성이 크게 확대되고 있습니다. 의료 서비스 제공업체, 임상 실험실, 현장 진료 검사 시설은 HSV 검사 솔루션에 대한 수요를 촉진하는 주요 최종 사용자를 구성하고 있습니다. 시장 상황은 신속한 진단 검사, 정확도를 높인 분자진단, 워크플로우 효율성을 향상시키는 자동 검사 플랫폼 개발 등 지속적인 기술 발전으로 특징지어집니다. 또한, 디지털 헬스 솔루션과 원격 의료 플랫폼의 통합은 특히 원격지나 의료 서비스가 부족한 지역에서 HSV 검사를 쉽게 이용할 수 있는 새로운 길을 열어주었습니다. 시장의 진화는 새로운 검사 방법에 대한 규제 당국의 승인, 의료비 지출 증가, 기밀성과 편의성이 높은 검사 옵션에 대한 환자 선호도 증가에 의해 더욱 영향을 받고 있습니다.
시장 역학
세계 HSV 검사 시장은 다양한 헬스케어 환경에서 시장 확대와 채택률을 높이는 몇 가지 주요 촉진요인에 의해 주도되고 있습니다. 주요 촉진요인은 단순 헤르페스 바이러스 감염의 전 세계적 확산에 기인하며, WHO 추정에 따르면 전 세계 50세 이하 인구 중 37억 명 이상이 HSV-1 감염을 앓고 있고, 15-49세 인구 중 4억 9,100만 명이 HSV-2 감염을 앓고 있어 정확한 진단 솔루션에 대한 수요는 매우 큽니다. 솔루션에 대한 큰 수요가 발생하고 있습니다.
분자진단의 기술적 진보, 특히 실시간 PCR과 차세대 시퀀싱 기술은 기존 검사법에 비해 우수한 민감도와 특이성, 빠른 납기를 제공함으로써 중요한 성장의 기폭제가 되고 있습니다. 성병에 대한 인식이 높아지고 예방의학에 대한 관심이 높아지면서 시장 수요를 더욱 자극하고 있습니다. 그러나 첨단 분자진단 장비 및 검사 절차에 따른 높은 비용 등 시장 진입장벽이 높아 자원이 제한된 의료 환경에서의 활용이 제한되고 있는 실정입니다. 또한, HSV 검사와 관련된 사회적 낙인이 심리적 장벽이 되어 진단 서비스를 받으려는 개인의 의욕을 떨어뜨려 시장 성장을 제한할 수 있습니다. 복잡한 규제와 새로운 진단약의 승인에 걸리는 시간도 혁신적인 솔루션을 도입하려는 시장 관계자들에게 도전이 되고 있습니다. 이러한 제약에도 불구하고, 포인트 오브 케어 검사 기능의 확대, 프라이버시와 편의성을 제공하는 재택 검사 키트의 채택 확대, 헬스케어 인프라가 개선되고 있는 신흥 시장에서의 보급 확대 등은 큰 비즈니스 기회를 창출하고 있습니다. 진단 플랫폼에 인공지능과 머신러닝의 통합은 정확도 향상과 결과 자동 해석의 기회를 제공하고, 진단 기업과 원격 의료 플랫폼의 제휴는 새로운 유통 채널을 창출하고, 의료 서비스를 받지 못하는 사람들의 검사 접근성을 향상시킬 수 있습니다.
본 조사의 주요 특징
- 세계의 HSV 검사 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 HSV 검사 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 HSV 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 HSV 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- Porter's Five Forces 분석
- 인수합병(M&A) 시나리오
- 산업 동향
제4장 세계의 HSV 검사 시장, HSV 유형별, 2020-2032년(100만 달러)
- 서론
- HSV-2 검사
- HSV-1 검사
- HSV형 미지정/복합 검사
제5장 세계의 HSV 검사 시장, 유형별, 2020-2032년
- 서론
- 직접 감지 또는 배양 검사(바이러스 배양)
- 분자 검사(PCR 검사, TMA 검사, NAAT 등)
- 혈청학적 검사(항체 감지 등)
- 신속 항원 검사(면역 크로마토그래피)
- 기타(산전 스크리닝 패널, 자택 채취 키트 등)
제6장 세계의 HSV 검사 시장, 샘플 유형별, 2020-2032년
- 서론
- 혈액/혈청/혈장
- 수포 스왑/체액
- 궤양/딱지 스왑
- 뇌척수액(CSF)
- 기타 체액(예 : 기관지 폐포 세정액)
제7장 세계의 HSV 검사 시장, 연령층별, 2020-2032년
- 서론
- 유아 및 신생아
- 어린이
- 성인
- 고령자
제8장 세계의 HSV 검사 시장, 용도별, 2020-2032년
- 서론
- 임상 질환 진단
- 역학연구(스크리닝)
- 모니터링 및 모니터링
- 기타
제9장 세계의 HSV 검사 시장, 최종사용자별, 2020-2032년
- 서론
- 병원
- 임상 진단실험실
- 홈케어
- POC(Point of Care) 환경
- 혈액은행 및 혈장 채취 센터
- 기타(연구 및 학술기관)
제10장 세계의 HSV 검사 시장, 지역별, 2020-2032년, 가치
- 서론
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN 국가
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙아프리카
제11장 경쟁 구도
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- BioMerieux
- Thermo Fisher Scientific
- Hologic Inc.
- BD(Becton Dickinson)
- Cepheid
- Quidel Corporation
- DiaSorin
- PerkinElmer
- Beckman Coulter
- Agilent Technologies
- Sysmex Corporation
- Ortho Clinical Diagnostics
제12장 애널리스트 추천 사항
- 기회
- COP(Coherent Opportunity Map)
제13장 참고 문헌과 조사 방법
- 참고 문헌
- 조사 방법
- 출판사에 대해
HSV Testing Market is estimated to be valued at USD 642.4 Mn in 2025 and is expected to reach USD 972.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 642.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.10% | 2032 Value Projection: | USD 972.3 Mn |
The global HSV testing market represents a critical segment within the broader diagnostic testing industry, focusing on the detection and identification of Herpes Simplex Virus infections that affect millions of individuals worldwide. HSV testing encompasses various diagnostic methodologies including PCR-based assays, antigen detection tests, antibody-based serological tests, and viral culture techniques, each designed to identify HSV-1 and HSV-2 infections with varying degrees of sensitivity and specificity.
The market's significance has grown substantially, due to increasing awareness about sexually transmitted infections, rising prevalence of herpes infections globally, and the growing emphasis on early diagnosis and treatment intervention. Healthcare providers, clinical laboratories, and point-of-care testing facilities constitute the primary end-users driving demand for HSV testing solutions. The market landscape is characterized by continuous technological advancements, including the development of rapid diagnostic tests, molecular diagnostics with enhanced accuracy, and automated testing platforms that improve workflow efficiency. Additionally, the integration of digital health solutions and telemedicine platforms has created new avenues for HSV testing accessibility, particularly in remote and underserved regions. The market's evolution is further influenced by regulatory approvals for novel testing methodologies, increasing healthcare expenditure, and growing patient preference for confidential and convenient testing options.
Market Dynamics
The global HSV testing market is propelled by several key drivers that collectively enhance market expansion and adoption rates across diverse healthcare settings. The primary driver stems from the escalating global prevalence of herpes simplex virus infections, with WHO estimates indicating that over 3.7 billion people under age 50 have HSV-1 infection and 491 million people aged 15-49 have HSV-2 infection worldwide, creating substantial demand for accurate diagnostic solutions.
Technological advancements in molecular diagnostics, particularly real-time PCR and next-generation sequencing techniques, serve as significant growth catalysts by offering superior sensitivity, specificity, and rapid turnaround times compared to traditional testing methods. Increasing awareness campaigns about sexually transmitted infections and growing emphasis on preventive healthcare measures further stimulate market demand. However, the market faces notable restraints including high costs associated with advanced molecular diagnostic equipment and testing procedures, which limit accessibility in resource-constrained healthcare settings. Additionally, social stigma associated with HSV testing creates psychological barriers that discourage individuals from seeking diagnostic services, potentially limiting market growth. Regulatory complexities and lengthy approval processes for new diagnostic products also pose challenges for market players seeking to introduce innovative solutions. Despite these constraints, significant opportunities emerge from expanding point-of-care testing capabilities, increasing adoption of home-based testing kits that offer privacy and convenience, and growing penetration in emerging markets with improving healthcare infrastructure. The integration of artificial intelligence and machine learning in diagnostic platforms presents opportunities for enhanced accuracy and automated result interpretation, while partnerships between diagnostic companies and telemedicine platforms create new distribution channels and improve testing accessibility in underserved populations.
Key features of the study
- This report provides an in-depth analysis of the global HSV Testing market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global HSV testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, BioMerieux, Thermo Fisher Scientific, Hologic Inc., BD (Becton Dickinson), Cepheid, Quidel Corporation, DiaSorin, PerkinElmer, Beckman Coulter, Agilent Technologies, Sysmex Corporation, and Ortho Clinical Diagnostics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global HSV testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HSV testing market.
Market Segmentation
- HSV Type Insights (Revenue, USD Mn, 2020 - 2032)
- HSV-2 Testing
- HSV-1 Testing
- HSV Type-Unspecified/Combined Tests
- Type Insights (Revenue, USD Mn, 2020 - 2032)
- Direct Detection or Culture Test (Viral Culture)
- Molecular Test (PCR Tests, TMA Tests, NAATs etc.)
- Serological Tests (Antibody Detection etc.)
- Rapid Antigen Tests (Immunochromatographic)
- Others (Prenatal Screening Panels and Home Collection Kits, etc.)
- Sample Type Insights (Revenue, USD Mn, 2020 - 2032)
- Blood/Serum/Plasma
- Vesicular Swab/Fluid
- Ulcer/Crust Swab
- Cerebrospinal Fluid (CSF)
- Other Body Fluids (e.g., Bronchoalveolar Lavage)
- Age Group Insights (Revenue, USD Mn, 2020 - 2032)
- Infants and Neonates
- Children
- Adults
- Elderly
- Application Insights (Revenue, USD Mn, 2020 - 2032)
- Clinical Disease Diagnosis
- Epidemiological Studies (Screening)
- Surveillance and Monitoring
- Others
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals
- Clinical Diagnostic Laboratories
- Home Care Settings
- Point-of-care Settings
- Blood Banks and Plasma Collection Centers
- Others (Research and Academic Institutes)
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- BioMerieux
- Thermo Fisher Scientific
- Hologic Inc.
- BD (Becton Dickinson)
- Cepheid
- Quidel Corporation
- DiaSorin
- PerkinElmer
- Beckman Coulter
- Agilent Technologies
- Sysmex Corporation
- Ortho Clinical Diagnostics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global HSV Testing Market, By HSV Type
- Global HSV Testing Market, By Type
- Global HSV Testing Market, By Sample Type
- Global HSV Testing Market, By Age Group
- Global HSV Testing Market, By Application
- Global HSV Testing Market, By End User
- Global HSV Testing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global HSV Testing Market, By HSV Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- HSV-2 Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- HSV-1 Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- HSV Type-Unspecified/Combined Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global HSV Testing Market, By Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Direct Detection or Culture Test (Viral Culture)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Molecular Test (PCR Tests, TMA Tests, NAATs etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Serological Tests (Antibody Detection etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Rapid Antigen Tests (Immunochromatographic)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (Prenatal Screening Panels and Home Collection Kits, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global HSV Testing Market, By Sample Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Blood/Serum/Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Vesicular Swab/Fluid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Ulcer/Crust Swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Cerebrospinal Fluid (CSF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Other Body Fluids (e.g., Bronchoalveolar Lavage)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global HSV Testing Market, By Age Group, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Infants and Neonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Children
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Elderly
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global HSV Testing Market, By Application, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Clinical Disease Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Epidemiological Studies (Screening)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Surveillance and Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global HSV Testing Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Clinical Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Point-of-care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Blood Banks and Plasma Collection Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (Research and Academic Institutes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
10. Global HSV Testing Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By HSV Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BD (Becton Dickinson)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cepheid
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quidel Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DiaSorin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beckman Coulter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ortho Clinical Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
